{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:25:25Z","timestamp":1793301925137,"version":"4.5.0"},"reference-count":238,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia \u2013 Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior"},{"name":"Marie Sk\u0142odowska-Curie Research and Innovation Staff Exchange"},{"name":"INPACT","award":["644167"],"award-info":[{"award-number":["644167"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Distrito Federal"},{"DOI":"10.13039\/501100005672","name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul","doi-asserted-by":"publisher","award":["PTDC\/BBB-BQB\/3494\/2014"],"award-info":[{"award-number":["PTDC\/BBB-BQB\/3494\/2014"]}],"id":[{"id":"10.13039\/501100005672","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FCT-MCTES","award":["SPRH\/BD\/52431\/2013"],"award-info":[{"award-number":["SPRH\/BD\/52431\/2013"]}]},{"name":"FCT-MCTES","award":["SPRH\/BD\/95624\/2013"],"award-info":[{"award-number":["SPRH\/BD\/95624\/2013"]}]},{"name":"FCT-MCTES","award":["SPRH\/BD\/100517\/2014"],"award-info":[{"award-number":["SPRH\/BD\/100517\/2014"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biotechadv.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T14:47:08Z","timestamp":1515509228000},"page":"415-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["Designing improved active peptides for therapeutic approaches against infectious diseases"],"prefix":"10.1016","volume":"36","author":[{"given":"B\u00e1rbara","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo T.","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio R.","family":"Fel\u00edcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oct\u00e1vio L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3nia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2018.01.004_bb0005","doi-asserted-by":"crossref","first-page":"D1098","DOI":"10.1093\/nar\/gkv1266","article-title":"CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides","volume":"44","author":"Agrawal","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0010","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/fmc.12.76","article-title":"Peptides and peptide conjugates: therapeutics on the upward path","volume":"4","author":"Ahrens","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0015","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/AAC.01424-07","article-title":"Inhibition of herpes simplex virus type 1 infection by cationic-peptides","volume":"52","author":"Akkarawongsa","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0020","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4155\/fmc.12.94","article-title":"Therapeutic peptides","volume":"4","author":"Albericio","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0025","doi-asserted-by":"crossref","first-page":"27536","DOI":"10.1074\/jbc.M110.130955","article-title":"Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR","volume":"285","author":"Alves","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jmv.20171","article-title":"Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface","volume":"74","author":"Andersen","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp0804651","article-title":"Antibiotic-resistant bugs in the 21st century \u2014 a clinical super-challenge","volume":"360","author":"Arias","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0040","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","article-title":"Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory","volume":"51","author":"Arnold","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00468-11","article-title":"Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B","volume":"56","author":"Arnusch","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0050","doi-asserted-by":"crossref","first-page":"13930","DOI":"10.3748\/wjg.v20.i38.13930","article-title":"Acute bacterial infection negatively impacts cancer specific survival of colorectal cancer patients","volume":"20","author":"Atti\u00ea","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0055","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jac\/dkt529","article-title":"Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure","volume":"69","author":"Augusto","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0060","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/molecules22071190","article-title":"Antiviral lipopeptide-cell membrane interaction is influenced by PEG linker length","volume":"22","author":"Augusto","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.colsurfb.2017.01.032","article-title":"Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies","volume":"152","author":"Augusto","year":"2017","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0070","doi-asserted-by":"crossref","first-page":"51407","DOI":"10.1039\/C6RA06877D","article-title":"Determination of the secondary structure of peptides in the presence of Gram positive bacterium S. epidermidis cells","volume":"6","author":"Avitabile","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0075","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbamem.2014.04.015","article-title":"Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity","volume":"1838","author":"Badani","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0080","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s11095-014-1550-9","article-title":"Cell-penetrating antimicrobial peptides \u2013 prospectives for targeting intracellular infections","volume":"32","author":"Bahnsen","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1208\/s12248-014-9688-2","article-title":"Physicochemical and formulation developability assessment for therapeutic peptide delivery\u2014a primer","volume":"17","author":"Bak","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0090","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.00835-07","article-title":"Lipid raft disruption by cholesterol depletion enhances influenza a virus budding from MDCK cells","volume":"81","author":"Barman","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0095","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbamem.2015.10.013","article-title":"Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria","volume":"1858","author":"Batoni","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0005-2736(99)00205-9","article-title":"The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy","volume":"1462","author":"Bechinger","year":"1999","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0110","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1128\/JVI.02312-14","article-title":"The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles","volume":"89","author":"Boso","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0115","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbamem.2009.10.019","article-title":"Role of guanidinium group in the insertion of l-arginine in DMPE and DMPC lipid interphases","volume":"1798","author":"Bouchet","year":"2010","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0120","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/JVI.80.9.4469-4481.2006","article-title":"Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques","volume":"80","author":"Brenner","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0125","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.peptides.2011.09.012","article-title":"Functional characterization of codCath, the mature cathelicidin antimicrobial peptide from Atlantic cod (Gadus morhua)","volume":"32","author":"Broekman","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.42.1.154","article-title":"The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II","volume":"42","author":"Brotz","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0140","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0145","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/bi0620297","article-title":"Structure and mechanism of action of the antimicrobial peptide piscidin","volume":"46","author":"Campagna","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0150","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/AAC.00904-16","article-title":"Esculentin-1a-derived peptides promote clearance of P. aeruginosa internalized in cystic fibrosis bronchial cells as well as lung cells migration: biochemical properties and a plausible mode of action","volume":"60","author":"Cappiello","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0155","doi-asserted-by":"crossref","first-page":"21385","DOI":"10.1038\/srep21385","article-title":"A polyalanine peptide derived from polar fish with anti-infectious activities","volume":"6","author":"Cardoso","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.virol.2008.12.031","article-title":"HIV entry in macrophages is dependent on intact lipid rafts","volume":"386","author":"Carter","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0170","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/JVI.06796-11","article-title":"Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins","volume":"86","author":"Carvalho","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0175","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bbamem.2006.04.006","article-title":"Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action","volume":"1758","author":"Chan","year":"2006","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/cbic.201300034","article-title":"Cyclization of the antimicrobial peptide gomesin with native chemical ligation: influences on stability and bioactivity","volume":"14","author":"Chan","year":"2013","journal-title":"ChemBioChem"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0185","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0190","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1128\/AAC.00925-06","article-title":"Role of peptide hydrophobicity in the mechanism of action of -helical antimicrobial peptides","volume":"51","author":"Chen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0195","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.0712380105","article-title":"A virocidal amphipathic \u03b1-helical peptide that inhibits hepatitis C virus infection in vitro","volume":"105","author":"Cheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcis.2009.11.057","article-title":"Chain length dependence of antimicrobial peptide\u2013fatty acid conjugate activity","volume":"345","author":"Chu-Kung","year":"2010","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2014.00022","article-title":"Biofilm disrupting technology for orthopedic implants: What's on the horizon?","volume":"1","author":"Connaughton","year":"2014","journal-title":"Front. Med."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0210","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0220","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1021\/acschembio.6b00386","article-title":"Protease-resistant and cell-permeable double-stapled peptides targeting the Rab8a GTPase","volume":"11","author":"Cromm","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/bc034119j","article-title":"A comparative study of different presentation strategies for an HIV peptide immunogen","volume":"15","author":"Cruz","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0230","doi-asserted-by":"crossref","first-page":"e73659","DOI":"10.1371\/journal.pone.0073659","article-title":"The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus","volume":"8","author":"Currie","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/bmc-2015-0014","article-title":"Defense peptides: recent developments","volume":"6","author":"Cytry\u0144ska","year":"2015","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0240","article-title":"The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts","volume":"0","author":"da Cunha","year":"2016","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbamcr.2003.10.001","article-title":"Effects of the antimicrobial peptide PGLa on live Escherichia coli","volume":"1643","author":"da Silva","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0250","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/bc3002248","article-title":"Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation","volume":"23","author":"Danial","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/iub.1257","article-title":"Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies","volume":"66","author":"de Figueiredo","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","article-title":"d-Enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections","volume":"22","author":"de la Fuente-N\u00fa\u00f1ez","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0265","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00726-015-2041-y","article-title":"d-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions","volume":"47","author":"Di Grazia","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08927014.2015.1021340","article-title":"BaAMPs: the database of biofilm-active antimicrobial peptides","volume":"31","author":"Di Luca","year":"2015","journal-title":"Biofouling"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0275","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood.V90.5.1751","article-title":"Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection","volume":"90","author":"Diamond","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00775","article-title":"New potent membrane-targeting antibacterial peptides from viral capsid proteins","volume":"8","author":"Dias","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0285","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0290","doi-asserted-by":"crossref","first-page":"e00248","DOI":"10.1042\/BSR20150060","article-title":"PvD1 defensin, a plant antimicrobial peptide with inhibitory activity against Leishmania amazonensis","volume":"35","author":"do Nascimento","year":"2015","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0295","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nano.2013.11.002","article-title":"Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria","volume":"10","author":"Domingues","year":"2014","journal-title":"Nanomedicine (NBM)"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0300","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1016\/j.biomaterials.2014.06.005","article-title":"Antimicrobial potency and selectivity of simplified symmetric-end peptides","volume":"35","author":"Dong","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u201cbug and drug\u201d","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0310","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12154-008-0010-6","article-title":"Sterols and membrane dynamics","volume":"1","author":"Dufourc","year":"2008","journal-title":"J. Chem. Biol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0315","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/acsinfecdis.6b00045","article-title":"Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of \u03b2-hairpin peptides","volume":"2","author":"Edwards","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0320","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/647938","article-title":"Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD","volume":"50","author":"Eisenstein","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0325","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00726-014-1801-4","article-title":"Vipericidins: a novel family of cathelicidin-related peptides from the venom gland of South American pit vipers","volume":"46","author":"Falcao","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0330","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00726-014-1686-2","article-title":"Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase","volume":"46","author":"Falciani","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0335","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nano.2013.06.004","article-title":"Dengue virus capsid protein interacts specifically with very low-density lipoproteins","volume":"10","author":"Faustino","year":"2014","journal-title":"Nanomedicine (NBM)"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0340","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/cb500640t","article-title":"Understanding dengue virus capsid protein disordered N-terminus and pep14-23-based inhibition","volume":"10","author":"Faustino","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0345","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1038\/srep10592","article-title":"Understanding dengue virus capsid protein interaction with key biological targets","volume":"5","author":"Faustino","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fchem.2017.00005","article-title":"Peptides with dual antimicrobial and anticancer activities","volume":"5","author":"Fel\u00edcio","year":"2017","journal-title":"Front. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0355","doi-asserted-by":"crossref","first-page":"e01554","DOI":"10.1128\/JVI.01554-16","article-title":"In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence","volume":"91","author":"Figueira","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0360","first-page":"31","article-title":"Designing antimicrobial peptides: form follows function","volume":"2","author":"Fjell","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0365","series-title":"Peptide Chemistry and Drug Design","first-page":"1","article-title":"Peptide therapeutics","author":"Fotouhi","year":"2015"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0370","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nbt0812-733","article-title":"Rare-disease drugs boosted by new prescription drug user fee act","volume":"30","author":"Fox","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0375","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1021\/ja711247n","article-title":"Sifuvirtide screens rigid membrane surfaces. Establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides","volume":"130","author":"Franquelim","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0380","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bbamem.2010.02.010","article-title":"Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes","volume":"1798","author":"Franquelim","year":"2010","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0385","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbamem.2013.03.006","article-title":"Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach","volume":"1828","author":"Franquelim","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2016.11.027","article-title":"siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model","volume":"245","author":"Freire","year":"2017","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0395","doi-asserted-by":"crossref","first-page":"24015","DOI":"10.1074\/jbc.M009691200","article-title":"Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria","volume":"276","author":"Friedrich","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0400","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1074\/jbc.M007540200","article-title":"Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery","volume":"276","author":"Futaki","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0405","first-page":"11220","article-title":"Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized","volume":"77","author":"Gah\u00e9ry-S\u00e9gard","year":"2003","journal-title":"Society"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0410","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1128\/JVI.77.9.5098-5108.2003","article-title":"Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription","volume":"77","author":"Gastaminza","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0415","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1479-5876-11-74","article-title":"In silico approaches for designing highly effective cell penetrating peptides","volume":"11","author":"Gautam","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0420","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/138161210793292555","article-title":"Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization","volume":"16","author":"Gentilucci","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0425","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/molecules22111869","article-title":"Biophysical properties and antiviral activities of measles fusion protein derived peptide conjugated with 25-hydroxycholesterol","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0430","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/bip.22088","article-title":"Lipid composition is a determinant for human defensin hnp1 selectivity","volume":"98","author":"Gon\u00e7alves","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0435","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.bbamem.2012.02.012","article-title":"Evaluation of the membrane lipid selectivity of the pea defensin Psd1","volume":"1818","author":"Gon\u00e7alves","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0440","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fcimb.2017.00249","article-title":"Psd1 effects on Candida albicans planktonic cells and biofilms","volume":"7","author":"Gon\u00e7alves","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0445","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713680590968637","article-title":"A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0450","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.2174\/138161211798999438","article-title":"Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery","volume":"17","author":"Gould","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0455","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0460","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14787210.5.6.951","article-title":"Alternative mechanisms of action of cationic antimicrobial peptides on bacteria","volume":"5","author":"Hale","year":"2007","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0465","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/bm500246w","article-title":"PEG\u2013Peptide Conjugates","volume":"15","author":"Hamley","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0470","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2180-10-22","article-title":"BACTIBASE second release: a database and tool platform for bacteriocin characterization","volume":"10","author":"Hammami","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0475","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","article-title":"Oral delivery of peptide drugs: barriers and developments","volume":"19","author":"Hamman","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0480","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0485","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri.2016.29","article-title":"The immunology of host defence peptides: beyond antimicrobial activity","volume":"16","author":"Hancock","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0490","doi-asserted-by":"crossref","first-page":"a004762","DOI":"10.1101\/cshperspect.a004762","article-title":"Distribution and functions of sterols and sphingolipids","volume":"3","author":"Hannich","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0495","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.4049\/jimmunol.176.11.6962","article-title":"Innate defense against influenza a virus: activity of human neutrophil defensins and interactions of Defensins with surfactant protein D","volume":"176","author":"Hartshorn","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0500","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1021\/jm400423p","article-title":"A general method for making peptide therapeutics resistant to serine protease degradation: application to dipeptidyl peptidase IV substrates","volume":"56","author":"Heard","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20061100","article-title":"Cell-penetrating peptides and antimicrobial peptides: how different are they?","volume":"399","author":"Henriques","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0510","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.bmcl.2013.07.056","article-title":"C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain\u2013side chain crosslinking","volume":"23","author":"Higgins","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0515","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nbt1113","article-title":"High-throughput generation of small antibacterial peptides with improved activity","volume":"23","author":"Hilpert","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0520","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chembiol.2008.11.006","article-title":"Screening and characterization of surface-tethered cationic peptides for antimicrobial activity","volume":"16","author":"Hilpert","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0525","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2217\/fmb.10.125","article-title":"Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"5","author":"H\u00f8iby","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0530","doi-asserted-by":"crossref","first-page":"e60302","DOI":"10.1371\/journal.pone.0060302","article-title":"Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action","volume":"8","author":"Hollmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0535","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.colsurfb.2016.02.003","article-title":"Role of amphipathicity and hydrophobicity in the balance between hemolysis and peptide\u2013membrane interactions of three related antimicrobial peptides","volume":"141","author":"Hollmann","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0540","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2017.03.018","article-title":"An amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing influenza viruses","volume":"46","author":"Holthausen","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0545","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/btt518","article-title":"CPPpred: prediction of cell penetrating peptides","volume":"29","author":"Holton","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0550","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0006-2952(99)00259-2","article-title":"Effect of d-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide","volume":"58","author":"Hong","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ph9030053","article-title":"The role of antimicrobial peptides in influenza virus infection and their potential as antiviral and immunomodulatory therapy","volume":"9","author":"Hsieh","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0560","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/psc.2958","article-title":"Biological and structural effects of the conjugation of an antimicrobial decapeptide with saturated, unsaturated, methoxylated and branched fatty acids","volume":"23","author":"H\u00fampola","year":"2017","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0565","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0570","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.bbamem.2016.07.001","article-title":"Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan","volume":"1858","author":"Irazazabal","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep04378","article-title":"Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells","volume":"4","author":"Jo","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0580","first-page":"73","article-title":"N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity","volume":"13","author":"John","year":"2008","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0585","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2012.20.1.019","article-title":"Cyclic peptides as therapeutic agents and biochemical tools","volume":"20","author":"Joo","year":"2012","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0590","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.bbamem.2015.01.007","article-title":"Helical cationic antimicrobial peptide length and its impact on membrane disruption","volume":"1848","author":"Juba","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12275-017-6452-1","article-title":"The therapeutic applications of antimicrobial peptides (AMPs): a patent review","volume":"55","author":"Kang","year":"2017","journal-title":"J. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0600","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0605","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tibs.2015.10.004","article-title":"Mechanism matters: a taxonomy of cell penetrating peptides","volume":"40","author":"Kauffman","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0610","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/dkt322","article-title":"De novo generation of short antimicrobial peptides with enhanced stability and cell specificity","volume":"69","author":"Kim","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0615","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/pr.113.008367","article-title":"Novel delivery systems for improving the clinical use of peptides","volume":"67","author":"Kovalainen","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpc.2015.02.005","article-title":"N-terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine \u03b2-defensin-2 results in salt-resistant antibacterial activity","volume":"199","author":"Krishnakumari","year":"2015","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0625","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0630","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2015.01.030","article-title":"Cell penetrating peptide conjugated liposomes as transdermal delivery system of Polygonum aviculare L. extract","volume":"483","author":"Kwon","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0635","doi-asserted-by":"crossref","first-page":"35015","DOI":"10.1074\/jbc.M114.591826","article-title":"Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation","volume":"289","author":"Lacek","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0640","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1186\/1471-2105-11-S1-S19","article-title":"AntiBP2: improved version of antibacterial peptide prediction","volume":"11","author":"Lata","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0645","first-page":"10","article-title":"The future of peptide development in the pharmaceutical industry","volume":"4","author":"Lax","year":"2010","journal-title":"PharManufacturing Int. Pept. Rev."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0650","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1039\/c004684a","article-title":"Lipo-oligoarginines as effective delivery vectors to promote cellular uptake","volume":"6","author":"Lee","year":"2010","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0655","doi-asserted-by":"crossref","first-page":"42141","DOI":"10.1074\/jbc.M111.254243","article-title":"Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0660","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2017.06.002","article-title":"Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications","volume":"95","author":"Lee","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0665","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.watres.2008.08.015","article-title":"Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications","volume":"42","author":"Li","year":"2008","journal-title":"Water Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0670","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbamem.2016.03.005","article-title":"Antimicrobial peptides: cell membrane and microbial surface interactions","volume":"1858","author":"Lohner","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0675","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12016-016-8554-7","article-title":"Zika virus infection: current concerns and perspectives","volume":"51","author":"Maharajan","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0680","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/bi052150y","article-title":"Effect of natural l- to d-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H","volume":"45","author":"Mangoni","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0685","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20112219","article-title":"The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif","volume":"444","author":"Martins","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0690","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.peptides.2015.07.009","article-title":"Antimicrobial activity of human \u03b1-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs","volume":"71","author":"Mathew","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0695","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/psc.2821","article-title":"Antimicrobial activity of human \u03b1-defensin 6 analogs: insights into the physico-chemical reasons behind weak bactericidal activity of HD6 in vitro","volume":"21","author":"Mathew","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0700","doi-asserted-by":"crossref","first-page":"43610","DOI":"10.1038\/srep43610","article-title":"Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides","volume":"7","author":"Mathieu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0705","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1038\/srep36617","article-title":"PEPlife: a repository of the half-life of peptides","volume":"6","author":"Mathur","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0710","doi-asserted-by":"crossref","first-page":"e9830","DOI":"10.1371\/journal.pone.0009830","article-title":"HIV-1 fusion inhibitor peptides Enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes","volume":"5","author":"Matos","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0715","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","article-title":"Control of cell selectivity of antimicrobial peptides","volume":"1788","author":"Matsuzaki","year":"2009","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0720","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cytogfr.2015.11.002","article-title":"Antimicrobial potentials and structural disorder of human and animal defensins","volume":"28","author":"Mattar","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0725","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.colsurfb.2017.02.003","article-title":"Lipid selectivity in novel antimicrobial peptides: implication on antimicrobial and hemolytic activity","volume":"153","author":"Maturana","year":"2017","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0730","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/499394a","article-title":"Antibiotic resistance: the last resort","volume":"499","author":"McKenna","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0735","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrmicro2095","article-title":"Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations","volume":"7","author":"Melo","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0740","doi-asserted-by":"crossref","first-page":"e28549","DOI":"10.1371\/journal.pone.0028549","article-title":"Prediction of antibacterial activity from physicochemical properties of antimicrobial peptides","volume":"6","author":"Melo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.02136","article-title":"Antimicrobial peptides from fruits and their potential use as biotechnological tools\u2014a review and outlook","volume":"7","author":"Meneguetti","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0750","doi-asserted-by":"crossref","first-page":"15615","DOI":"10.1021\/ja075373f","article-title":"Antimicrobial activity and protease stability of peptides containing fluorinated amino acids","volume":"129","author":"Meng","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0755","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41598-017-04462-6","article-title":"Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism","volume":"7","author":"Menzel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0760","doi-asserted-by":"crossref","first-page":"e47047","DOI":"10.1371\/journal.pone.0047047","article-title":"Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus","volume":"7","author":"Migliolo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0765","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.bbamem.2016.04.003","article-title":"Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2","volume":"1858","author":"Migliolo","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0770","doi-asserted-by":"crossref","first-page":"16883","DOI":"10.1073\/pnas.1108795108","article-title":"Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions","volume":"108","author":"Mishra","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0775","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imm.12646","article-title":"Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules","volume":"149","author":"Morita","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0780","doi-asserted-by":"crossref","first-page":"12383","DOI":"10.1038\/ncomms12383","article-title":"Crystal structure of the plant receptor-like kinase TDR in complex with the TDIF peptide","volume":"7","author":"Morita","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0785","doi-asserted-by":"crossref","first-page":"725","DOI":"10.18388\/abp.2015_1120","article-title":"Antimicrobial, antiadhesive and antibiofilm potential of lipopeptides synthesised by Bacillus subtilis, on uropathogenic bacteria","volume":"62","author":"Moryl","year":"2015","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0790","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00249-015-1094-x","article-title":"The effect of amidation on the behaviour of antimicrobial peptides","volume":"45","author":"Mura","year":"2016","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0795","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0800","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/S0006-3495(00)76784-1","article-title":"Conformation and dynamics of melittin bound to magnetically oriented lipid bilayers by solid-state 31P and 13C NMR spectroscopy","volume":"78","author":"Naito","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0805","doi-asserted-by":"crossref","first-page":"e77031","DOI":"10.1371\/journal.pone.0077031","article-title":"Effect of selectively introducing arginine and d-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins","volume":"8","author":"Olli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0810","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.01670-13","article-title":"Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging","volume":"58","author":"Ordonez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0815","series-title":"Peptide-Based Drug Design","first-page":"1","article-title":"Peptide-based drug design: here and now","author":"Otvos","year":"2008"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0820","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tube.2014.03.011","article-title":"Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects","volume":"94","author":"Padhi","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0825","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","article-title":"Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions","volume":"244","author":"Park","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0830","series-title":"Cell-Penetrating Peptides. Methods and Protocols, Methods in Molecular Biology","first-page":"223","article-title":"The antimicrobial and antiviral applications of cell-penetrating peptides","author":"P\u00e4rn","year":"2015"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0835","doi-asserted-by":"crossref","first-page":"e5285","DOI":"10.1371\/journal.pone.0005285","article-title":"End-tagging of ultra-short antimicrobial peptides by W\/F stretches to facilitate bacterial killing","volume":"4","author":"Pasupuleti","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0840","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/AAC.46.3.605-614.2002","article-title":"Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli","volume":"46","author":"Patrzykat","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0845","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10702","article-title":"Rethinking amide bond synthesis","volume":"480","author":"Pattabiraman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0850","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1098\/rspb.2005.3301","article-title":"Experimental evolution of resistance to an antimicrobial peptide","volume":"273","author":"Perron","year":"2006","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0855","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/psc.2706","article-title":"Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases","volume":"21","author":"Pessi","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0860","doi-asserted-by":"crossref","first-page":"e36833","DOI":"10.1371\/journal.pone.0036833","article-title":"A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity","volume":"7","author":"Pessi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0865","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/157016207781023947","article-title":"The antimicrobial peptide LL-37 inhibits HIV-1 replication","volume":"5","author":"Peter Bergman","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0870","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/md8020373","article-title":"Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges","volume":"8","author":"Pimentel-Elardo","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0875","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1128\/JB.00017-16","article-title":"Antibiofilm peptides: potential as broad-spectrum agents","volume":"198","author":"Pletzer","year":"2016","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0880","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1039\/c0md00111b","article-title":"Strategies to prolong the plasma residence time of peptide drugs","volume":"1","author":"Pollaro","year":"2010","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0885","doi-asserted-by":"crossref","first-page":"e1001168","DOI":"10.1371\/journal.ppat.1001168","article-title":"Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry","volume":"6","author":"Porotto","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0890","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biotechadv.2017.02.001","article-title":"Computational tools for exploring sequence databases as a resource for antimicrobial peptides","volume":"35","author":"Porto","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0895","doi-asserted-by":"crossref","first-page":"e54908","DOI":"10.1371\/journal.pone.0054908","article-title":"HIPdb: a database of experimentally validated HIV inhibiting peptides","volume":"8","author":"Qureshi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0900","doi-asserted-by":"crossref","first-page":"D1147","DOI":"10.1093\/nar\/gkt1191","article-title":"AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses","volume":"42","author":"Qureshi","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0905","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cbdd.12834","article-title":"AVCpred: an integrated web server for prediction and design of antiviral compounds","volume":"89","author":"Qureshi","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0910","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/psc.2894","article-title":"Short AntiMicrobial Peptides (SAMPs) as a class of extraordinary promising therapeutic agents","volume":"22","author":"Ramesh","year":"2016","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0915","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.molmed.2015.06.005","article-title":"Cell-penetrating peptides: strategies for anticancer treatment","volume":"21","author":"Raucher","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0920","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2016.05.013","article-title":"Antifungal peptides: to be or not to be membrane active","volume":"130","author":"Rautenbach","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0925","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2016.02.006","article-title":"New frontiers for anti-biofilm drug development","volume":"160","author":"Ribeiro","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0930","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.exppara.2012.12.009","article-title":"Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites","volume":"133","author":"Rico-Mata","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0935","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/bc200421z","article-title":"Efficient cellular delivery of \u03b2-galactosidase mediated by NrTPs, a new family of cell-penetrating peptides","volume":"22","author":"Rodrigues","year":"2011","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0940","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.bbamem.2012.06.014","article-title":"Molecular characterization of the interaction of crotamine-derived nucleolar targeting peptides with lipid membranes","volume":"1818","author":"Rodrigues","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0945","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.bbagen.2013.05.020","article-title":"Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes","volume":"1830","author":"Rodrigues","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0950","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/bip.22610","article-title":"Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types","volume":"104","author":"Rodrigues","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0955","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2180-14-140","article-title":"Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus","volume":"14","author":"Rothan","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0960","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.57.4.679","article-title":"New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0965","first-page":"1","article-title":"Peptides as \u201cdrugs\u201d: the journey so far","author":"Sachdeva","year":"2016","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0970","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","article-title":"A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses","volume":"48","author":"Sample","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0975","doi-asserted-by":"crossref","first-page":"e1000632","DOI":"10.1371\/journal.ppat.1000632","article-title":"Dengue virus capsid protein usurps lipid droplets for viral particle formation","volume":"5","author":"Samsa","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0980","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cis.2013.06.009","article-title":"Effect of hydrophobic modifications in antimicrobial peptides","volume":"205","author":"Schmidtchen","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0985","series-title":"Antimicrobial Peptides, Methods in Molecular Biology, Methods in Molecular Biology","author":"Schr","year":"2010"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0990","doi-asserted-by":"crossref","first-page":"D265","DOI":"10.1093\/nar\/gkl866","article-title":"Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides","volume":"35","author":"Seebah","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb0995","doi-asserted-by":"crossref","first-page":"D1108","DOI":"10.1093\/nar\/gkr1063","article-title":"DAMPD: a manually curated antimicrobial peptide database","volume":"40","author":"Seshadri Sundararajan","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1000","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/psc.2770","article-title":"Engineering of a linear inactive analog of human \u03b2-defensin 4 to generate peptides with potent antimicrobial activity","volume":"21","author":"Sharma","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1005","doi-asserted-by":"crossref","first-page":"21839","DOI":"10.1038\/srep21839","article-title":"dPABBs: a novel in silico approach for predicting and designing anti-biofilm peptides","volume":"6","author":"Sharma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1010","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1128\/AAC.48.12.4673-4679.2004","article-title":"Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases","volume":"48","author":"Sieprawska-Lupa","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2014.00097","article-title":"Defensins: antifungal lessons from eukaryotes","volume":"5","author":"Silva","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1020","doi-asserted-by":"crossref","first-page":"35465","DOI":"10.1038\/srep35465","article-title":"An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities","volume":"6","author":"Silva","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1025","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.3390\/v7102883","article-title":"Perspective of use of antiviral peptides against influenza virus","volume":"7","author":"Skalickova","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1030","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.3390\/molecules200713313","article-title":"Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo","volume":"20","author":"Skotland","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.molimm.2015.08.009","article-title":"Antimicrobial proteins: from old proteins, new tricks","volume":"68","author":"Smith","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.00477-08","article-title":"Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37","volume":"53","author":"Stromstedt","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6968.1998.tb12896.x","article-title":"Mechanism of antimicrobial action of indolicidin","volume":"160","author":"Subbalakshmi","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1050","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jps.20125","article-title":"Pharmacokinetic aspects of biotechnology products","volume":"93","author":"Tang","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1055","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.4049\/jimmunol.178.12.8046","article-title":"Human neutrophil defensins increase neutrophil uptake of influenza a virus and bacteria and modify virus-induced respiratory burst responses","volume":"178","author":"Tecle","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1060","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1111\/bph.13582","article-title":"High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice","volume":"173","author":"Thieme","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.bioconjchem.5b00023","article-title":"Macrocyclic cell penetrating peptides: a study of structure-penetration properties","volume":"26","author":"Traboulsi","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.0407677102","article-title":"Partial d-amino acid substitution: improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide","volume":"102","author":"Tugyi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0169-409X(02)00183-7","article-title":"Arginine containing peptides as delivery vectors","volume":"55","author":"Tung","year":"2003","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1080","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.42.9.2206","article-title":"Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils","volume":"42","author":"Turner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euprot.2014.05.003","article-title":"The emergence of peptides in the pharmaceutical business: from exploration to exploitation","volume":"4","author":"Uhlig","year":"2014","journal-title":"EuPA Open Proteomics"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1095","doi-asserted-by":"crossref","first-page":"e22871","DOI":"10.1002\/bip.22871","article-title":"Linear antimicrobial peptides with activity against herpes simplex virus 1 and Aichi virus","volume":"108","author":"Vilas Boas","year":"2017","journal-title":"Biopolymers"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1105","doi-asserted-by":"crossref","first-page":"D1094","DOI":"10.1093\/nar\/gkv1051","article-title":"CAMP R3: a database on sequences, structures and signatures of antimicrobial peptides: table 1","volume":"44","author":"Waghu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1110","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/AAC.00452-08","article-title":"Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins","volume":"52","author":"Wang","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1115","doi-asserted-by":"crossref","first-page":"e18476","DOI":"10.1371\/journal.pone.0018476","article-title":"Prediction of antimicrobial peptides based on sequence alignment and feature selection methods","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1120","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bip.22073","article-title":"Protease-resistant peptide design-empowering nature's fragile warriors against HIV","volume":"98","author":"Weinstock","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1130","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1128\/JVI.02436-13","article-title":"Fatal measles virus infection prevented by brain-penetrant fusion inhibitors","volume":"87","author":"Welsch","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1135","doi-asserted-by":"crossref","first-page":"593D","DOI":"10.1093\/nar\/gkh077","article-title":"The Peptaibol database: a database for sequences and structures of naturally occurring peptaibols","volume":"32","author":"Whitmore","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1140","doi-asserted-by":"crossref","first-page":"e0138426","DOI":"10.1371\/journal.pone.0138426","article-title":"New influenza a virus entry inhibitors derived from the viral fusion peptides","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1145","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1021\/jm300655h","article-title":"Critical effect of peptide cyclization on the potency of peptide inhibitors against dengue virus NS2B-NS3 protease","volume":"55","author":"Xu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-3495(98)77554-X","article-title":"Neutron off-plane scattering of aligned membranes. I. Method of measurement","volume":"75","author":"Yang","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1155","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/bph.13499","article-title":"Genetic fusion of human FGF21 to a synthetic polypeptide improves pharmacokinetics and pharmacodynamics in a mouse model of obesity","volume":"173","author":"Yin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/mp400446v","article-title":"A Myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery","volume":"11","author":"Youn","year":"2014","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00318","article-title":"Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships","volume":"4","author":"Zaman","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1175","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2174\/092986712799945003","article-title":"Converting peptides into drug leads by lipidation","volume":"19","author":"Zhang","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/mi.2008.81","article-title":"A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge","volume":"2","author":"Zhang","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1185","first-page":"1009","article-title":"Conjugation of cholesterol to HIV-1 fusion peptide CP32M improves its antiviral potency and retainment at the host cell membrane","volume":"3","author":"Zhang","year":"2016","journal-title":"Ann. Transl. Med. Epidemiol."},{"key":"10.1016\/j.biotechadv.2018.01.004_bb1190","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2006.08.094","article-title":"Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1","volume":"349","author":"Zhu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975018300041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975018300041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:21:23Z","timestamp":1693390883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975018300041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":238,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0734975018300041"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2018.01.004","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing improved active peptides for therapeutic approaches against infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}